Chemocentryx, Inc.
Records under this name other than the patents Chemocentryx, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 161 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,154,556 | Methods of Treating Solid Tumors with CCR2 Antagonists now held by The Regents of the University of California In force · High confidence | In force | High confidence | |
| US 12,758,558 | Methods of Treating Solid Tumors with CCR2 Antagonists now held by The Regents of the University of California In force · High confidence | In force | High confidence | |
| US 11,986,466 | Methods of Treating Solid Tumors with CCR2 Antagonists now held by The Regents of the University of California In force · High confidence | In force | High confidence | |
| US 12,448,373 | Azetidinyl-Acetamides as CXCR7 Inhibitors now held by Inc., Chemocentryx In force · High confidence | In force | High confidence | |
| US 7,557,213 | Substituted Quinolones and Methods of Use Term ended Term ended Nov 13, 2026 · High confidence | Term ended | Term ended Nov 13, 2026 | High confidence |
| US 7,932,252 | Aryl Sulfonamides Term ended Term ended Nov 5, 2026 · High confidence | Term ended | Term ended Nov 5, 2026 | High confidence |
| US 7,576,106 | Piperidine Derivatives and Methods of Use Term ended Ended no later than Oct 11, 2026 · Medium confidence | Term ended | Ended no later than Oct 11, 2026 | Medium confidence |
| US 7,576,218 | 4-Phenylpiperdine-PYRAZOLE CCR1 Antagonists Term ended Ended no later than Oct 11, 2026 · Medium confidence | Term ended | Ended no later than Oct 11, 2026 | Medium confidence |
| US 7,435,830 | Bicyclic and Bridged Nitrogen Heterocycles Term ended Term ended Oct 9, 2026 · High confidence | Term ended | Term ended Oct 9, 2026 | High confidence |
| US 7,678,891 | Antibodies That Bind CCX-CKR2 Term ended Term ended Jul 15, 2026 · High confidence | Term ended | Term ended Jul 15, 2026 | High confidence |